Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
Use this RNTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RNTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RNTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Rein Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RNTX income, balance, and cash tables.